
    
      CHILDNEPH is an ongoing prospective longitudinal study of children with incident and
      prevalent nephrotic syndrome. Children are recruited from 12 centres across Canada and
      followed for at least 30 months. The project starting in August of 2013 with the goal of
      following 400 patients. Data is collected at enrollment, beginning and end of each relapse,
      semi-annual visits and end of study. Detailed prescription data is collected regarding
      glucocorticoids and all second line agents. All relapses are recorded with time to urinary
      remission of proteinuria.

      The investigators are moving towards registry based trials to determine optimal treatment
      protocols for nephrotic syndrome with an overall goal to minimize glucocorticoid exposure, a
      patient priority.
    
  